Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis
Open Access
Abstract
Prostate cancer (PCa) is one of the most prevalent and malignant cancer types in men, which causes more than three-hundred thousand cancer death each year. At late stage of PCa progression, bone marrow is the most often metastatic site that constitutes almost 70% of metastatic cases of the PCa population. However, the characteristic for the osteo-philic property of PCa is still puzzling. Recent studies reported that the Wnt and Ras signaling pathways are pivotal in bone metastasis and that take parts in different cytological changes, but their crosstalk is not well studied. In this review, we focused on interactions between the Wnt and Ras signaling pathways during each stage of bone metastasis and present the fate of those interactions. This review contributes insights that can guide other researchers by unveiling more details with regard to bone metastasis and might also help in finding potential therapeutic regimens for preventing PCa bone metastasis.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST107-2628-B-038-001, MOST108-2628-B-038-001)
- National Health Research Institutes (NHRI-EX108-10702BI, NHRI-EX109-10702BI)
This publication has 164 references indexed in Scilit:
- Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor β-Initiated Prostate Cancer Epithelial-Mesenchymal TransitionMolecular and Cellular Biology, 2012
- MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer CellsJournal of Biological Chemistry, 2012
- Mixed Lineage Kinase 3 Modulates β-Catenin Signaling in Cancer CellsJournal of Biological Chemistry, 2011
- Phylogenetic-based propagation of functional annotations within the Gene Ontology consortiumBriefings in Bioinformatics, 2011
- NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivationOncogene, 2011
- Dickkopf‐1 (DKK‐1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastasesThe Prostate, 2010
- Metastatic Growth from Dormant Cells Induced by a Col-I–Enriched Fibrotic EnvironmentCancer Research, 2010
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κBNature Medicine, 2010
- Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesionsOncogene, 2009
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007